Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.03
-0.05 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
4.00
-0.62%
After-hours: Aug 15, 2025, 05:59 PM EDT

Cytek Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.58M -11.4M 9.64M 940K -10.43M -6.17M 5.5M -6.46M -4.39M -6.81M 3.72M 1.63M -702K -2.16M -1.17M 1.42M 2.67M 102K
Depreciation & Amortization
2.99M 2.88M 2.74M 2.81M 2.48M 2.46M 2.42M 2.56M 2.44M 1.8M 1.86M 771K 1.55M 1.47M 685K 189K 201K 167K
Stock-Based Compensation
6.79M 6.63M 7M 7.05M 7.15M 5.64M 5.67M 5.76M 5.92M 4.7M 4.46M 4.36M 3.93M 3.84M 3.01M 2.46M 667K 456K
Other Working Capital
n/a -2.33M 1.57M -9.49M -1.72M -7.78M -8.64M 1.76M 681K 521K 2.25M -5.09M 2.02M -1.02M 5.7M 2.51M 1.01M 1.82M
Other Non-Cash Items
-2.03M -930K -11.89M 12.37M 1.19M 1.12M 5.47M -3.81M 287K -528K 886K 739K 549K 572K 758K 439K 404K 372K
Deferred Income Tax
-2.06M -336K n/a n/a n/a n/a -5.72M 2.98M -2.02M n/a n/a n/a n/a n/a 155K 70K -58K 281K
Change in Working Capital
n/a 3.03M -5.5M -9.95M 8.11M 1.85M -3.84M -5.27M -5.09M 3.69M -4.74M -15M -14.99M -5.2M 2.01M -3.41M -7.8M 557K
Operating Cash Flow
108K -125K 2M 13.22M 6.2M 3.96M 9.51M -4.24M -2.85M 2.86M 6.19M -7.5M -9.44M -1.48M 5.45M 1.16M -3.91M 1.94M
Capital Expenditures
-1.58M -849K -903K -808K -1.2M -622K -1.56M -1.39M -1.37M -505K -6.61M -1.15M -1.33M -780K -1.3M -1.31M -1.25M -509K
Cash Acquisitions
n/a n/a -471K -76K 76K n/a -236K -1K -10M -45.13M n/a n/a n/a n/a -17M 371K n/a 371K
Purchase of Investments
-81.26M -60.16M -107.25M -52.83M -36.85M -77.13M -23.14M -23.48M -5.84M -123.24M -44.45M n/a -1.59M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
66.47M 70.43M 45M 38M 40M 72M 54M 68M 10M 235K n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-49K 31K 182K -98K 3.08M -55K 30.57M 44.69M 10M -235K -80K -40K -1.59M n/a -20.99M n/a n/a n/a
Investing Cash Flow
-16.41M 9.45M -63.43M -15.81M 2.02M -5.75M 29.07M 43.12M 2.79M -168.87M -51.06M -1.15M -2.92M -780K -18.3M -1.31M -1.25M -138K
Debt Repayment
n/a -828K 2.65M -135K -142K 1.25M -140K -138K -141K -146K 2.93M n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a -10.63M -6.99M -11.95M -2.67M -148K -34.74M -8.43M -981K -57K n/a -71K -67K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.67M -11.58M 705K 1K -130K 358K 2.25M 292K 357K 146K 917K 155K 1.14M 364K 17K 217.08M -3.72M 187K
Financial Cash Flow
-2.6M -11.54M -3.64M -12.08M -1.71M 1.61M -33.75M -8.27M 216K 203K 3.85M 155K 1.14M 364K 17K 217.08M -3.72M 187K
Net Cash Flow
-19.83M -3.45M -63.56M -15.62M 8.78M 1.51M 4M 32.09M -850K -167.11M -42.02M -8.37M -12.61M -2.11M -12.15M 216.93M -8.74M 2.46M
Free Cash Flow
-1.47M -974K 1.09M 12.41M 5M 3.33M 7.95M -5.63M -4.22M 2.35M -417K -8.65M -10.77M -2.26M 4.15M -147K -5.17M 1.43M